Expression, purification, electron microscopy, N-glycosylation mutagenesis and molecular modeling of human P2X4 and Dictyostelium discoideum P2XA by Valente, Maria et al.
Biochimica et Biophysica Acta 1808 (2011) 2859–2866
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemExpression, puriﬁcation, electron microscopy, N-glycosylation mutagenesis and
molecular modeling of human P2X4 and Dictyostelium discoideum P2XA
Maria Valente a,1, Summer J. Watterson b, Mark D. Parker b, Robert C. Ford c, Mark T. Young a,⁎
a School of Biosciences, Cardiff University, Museum Avenue, Cardiff, CF10 3AX, UK
b Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, 10900 Euclid Ave, Cleveland, OH, USA
c Manchester Interdisciplinary Biocentre, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UKAbbreviations: β-OG, n-octyl-β-D-glucoside; C12E8, oc
ether; DDM, n-dodecyl-β-D-maltoside; FC-12, n-dodecylp
cyl-N,N-dimethylamine-N-oxide; PBS, phosphate-buffere
sulfate; Sf9 cells, Spodoptera frugiperda cell-line derived f
mission electron microscopy, TX-100, Triton-X-100; zf, ze
⁎ Corresponding author at: School of Biosciences, Card
Cardiff, CF10 3AX, UK. Tel.: +44 2920879394; fax: +44 2
E-mail address: youngmt@cardiff.ac.uk (M.T. Young)
1 Present address: Department of Cell Biology, Unive
(Cosenza), Italy.
0005-2736/$ – see front matter © 2011 Elsevier B.V. All
doi:10.1016/j.bbamem.2011.08.025a b s t r a c ta r t i c l e i n f oArticle history:
Received 15 June 2011
Received in revised form 8 August 2011
Accepted 19 August 2011
Available online 26 August 2011
Keywords:
P2X
Sf9
TEM
Single particle analysis
N-glycosylation
ModellerThe recent publication of the apo-, closed-state 3D crystal structure of zebraﬁsh (zf) P2X4.1 has not only rev-
olutionized the P2X research ﬁeld, but also highlighted the need for further crystal structures, of receptors in
different activation states, so that we can gain a complete molecular understanding of ion channel function.
zfP2X4.1 was selected as a 3D-crystallization candidate because of its ability to form stable trimers in deter-
gent solution, and puriﬁed from over-expression in baculovirus-infected Spodoptera frugiperda (Sf9) insect
cells. In this work, we have used a similar approach to express both human P2X4 (hP2X4) and Dictyostelium
discoideum P2XA (DdP2XA) in Sf9 cells. Although hP2X4 did not form stable trimers in detergent solution,
both receptors bound to ATP-coupled resins, indicating that their extracellular domains were folded correct-
ly. DdP2XA formed strong trimers in detergent solution, and we were able to selectively purify trimers using
preparative electrophoresis, and build a 21 Å-resolution 3D structure using transmission electron microscopy
and single particle analysis. Although the structure of DdP2XA possessed similar dimensions to those of the
previously determined low-resolution hP2X4 structure and the zfP2X4.1 crystal structure, N-glycosylation
mutagenesis andmolecular modeling indicated differences between N-glycan usage and predicted accessibil-
ity in models of DdP2XA based on the zfP2X4.1 crystal structure. Our data demonstrate that DdP2XA
expressed in insect cells retains ATP-binding capacity after detergent solubilization, is an ideal candidate
for structural study, and possesses a signiﬁcantly different 3D structure to that of both hP2X4 and zfP2X4.1.taethylene glycol monododecyl
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P2X receptors are trimeric cation channels gated by extracellular
ATP. There are seven subtypes in mammals, which display differential
agonist/antagonist selectivity and ion channel properties [1], and play
roles in physiological processes such as nerve transmission, pain sen-
sation, control of vascular tone and inﬂammation, making them key
drug targets [2,3]. In addition, P2X receptors are found in zebraﬁsh
(zf) [4], and several lower eukaryotes including the slime mold
Dictyostelium discoideum[5]. The publication in 2009 of the ﬁrst crystal
structure of a P2X receptor, apo-zfP2X4.1 at 3.1 Å resolution [6] repre-
sents a major advance. Success with zfP2X4.1 was dependent uponthree main factors: (i) screening of many different receptor constructs
to ﬁnd those which formed the most stable trimers in detergent solution
[7]; (ii) use of the Sf9 insect cell expression system; and (iii) signiﬁcant
construct modiﬁcation to achieve well-diffracting crystals. The extensive
construct modiﬁcation altered ion channel function; peak currents were
reduced, channel closure after removal of agonist was delayed, and
agonist potency was increased [6], implying that the structure may not
represent a native conformation, but rather an artiﬁcially stabilized,
closed state. Nevertheless, it has enabled the interpretation of a large
quantity of previous experimental data relating to transmembrane
domain orientation, ligand-binding and channel opening in molecular
detail [8–10], and serves as an excellent template from which to
model other P2X receptors.
To fully understand the molecular basis of agonist/antagonist
binding, channel activation and subtype selectivity, further P2X re-
ceptor structures, including the ligand-bound state (in closed and
open conformation), and structures of different receptor subtypes
(particularly the mammalian receptors) are needed. Obtaining these
structures represents a huge challenge because it is difﬁcult to pro-
duce stable, folded P2X receptors in the milligram-quantities required
for 3D crystal trials. Thus far, successful over-expression of P2X recep-
tors for structural study has been achieved in mammalian cell lines
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baculovirus-infected Sf9 insect cells for rat P2X2 [14,15] and
zfP2X4.1 [6]. However, in most cases, the yield of protein has been
too low to permit 3D crystallography, and structural data have been
limited to low-resolution studies using atomic force microscopy
[11,12,15] and single particle analysis [13,14,16], which require sig-
niﬁcantly lower quantities of protein. By far the most successful
approach has been that of Kawate et al., determining the construct
most likely to produce a high yield of stable trimers, and expressing
this in Sf9 cells [6].
To exploit and extend this recent advance, we have employed the
Sf9 insect cell system to express both human P2X4 (hP2X4) and D.
discoideum P2XA (DdP2XA). hP2X4 is the nearest human homologue
to zfP2X4.1, sharing 57% amino acid identity. It has also been shown
to form a signiﬁcant proportion of stable trimers when over-
expressed in human cells [13]. DdP2XA is more distantly related to
zfP2X4.1, sharing only 16% amino acid identity. However, this protein
has been shown to form highly stable trimers when expressed in
human cells [5], which was an important indicator of success with
zfP2X4.1 [6].
We assessed the degree of trimer formation of each receptor in a
variety of detergents using non-denaturing perﬂuorooctanoic acid
(PFO)–PAGE, and found that while hP2X4 did not form stable trimers
in any of the detergents tested, DdP2XA was very stable in several
detergents, including n-dodecyl-β-D-maltoside (DDM). We also
assessed whether or not the receptors were folded by performing
pull-down assays with ATP-coupled sepharose beads; both receptors
bound to beads coupled to ATP at the γ-phosphate- or 6-amino-
position, but not at the 8-position, which may give some indication
of how ATP is positioned within the binding site. Following selective
puriﬁcation of DdP2XA trimers using preparative PFO–PAGE, electron
microscopy and single particle analysis were used to build a low-
resolution 3D structure of the receptor, which possessed pronounced
extracellular-domain propellers compared to the previously deter-
mined hP2X4. Finally, we generated molecular models of both hP2X4
and DdP2XA using the zfP2X4.1 crystal structure as the template, and
probed their accuracy using N-glycosylation mutagenesis, ﬁnding
several discrepancies between actual N-glycan usage in DdP2XA and
predicted residue accessibility.
Our data show that (i) wild-type hP2X4 expressed in insect cells
does not form stable trimers in detergent solution, but is still capable
of binding ATP; and (ii) wild-type DdP2XA forms stable trimers in
detergent, is an excellent candidate for over-expression in Sf9 cells for
structure determination, and that its overall 3D-structure appears to
be signiﬁcantly different to that predicted from molecular modeling
studies.
2. Experimental
2.1. cDNA constructs, mutagenesis, expression in HEK cells and Western
blotting
cDNA constructs corresponding to human P2X4-(His)10 and human
codon-optimized DdP2XA-(His)6 have been described previously
[5,13]. Site-directedmutagenesis was carried out using the QuikChange
kit (Stratagene) according tomanufacturers' instructions. HEK-293 cells
were cultured to approximately 80% conﬂuency in 35-mm dishes, and
transfected with 1 μg cDNA using 3 μl Lipofectamine (Invitrogen)
according to manufacturers' instructions. 24 hours post-transfection,
cells were washed twice in ice-cold phosphate-buffered saline (PBS,
Sigma) and pelleted by centrifugation at 4000g for 3 minutes. Total pro-
tein samples were prepared by solubilizing the cells from one 35-mm
dish in 50 μl PBS containing 1% (w/v) n-dodecyl-β-D-maltoside (DDM)
and protease inhibitors (Roche Complete—EDTA). Solubilized protein
concentrations were determined using Bradford assay, protein samples
were denatured by boiling for 2 minutes at 100 °C, separated by SDS–PAGE on 10% polyacrylamide gels (Bio-Rad) and transferred to PVDF
membranes. Membranes were blocked with 3% bovine serum albumin
(BSA) for 1 hour at room temperature and incubated in blocking buffer
withmouse monoclonal anti-His primary antibody (Qiagen; 1:2000 di-
lution) overnight at 4 °C. After washing in 3 changes of PBS containing
0.1% Tween-20 (PBS-T, Bio-Rad), membranes were incubated with
either alkaline phosphatase- or HRP-coupled secondary antibody
(Sigma or DAKO Cytomation; 1:2000) for 1 hour at room temperature
and washed 4× in PBS-T. Blots were developed using either BCIP/NBT
tablets (Sigma) or the ECL-Plus kit (GE Healthcare) according to manu-
facturers' instructions.
2.2. Generating recombinant bacmid for Sf9 expression
Our starting point was the above-mentioned clones which were
used as templates for PCR. cDNA encoding human P2X4-(His)10 and
human codon-optimized DdP2XA-(His)6 was ampliﬁed from these
templates to include a CACC sequence in place of the initiation
codon at the 5′ end and a termination codon at the 3′ end. The PCR
products were subcloned into an insect cell expression vector using
the Gateway system (Invitrogen, Carlsbad, CA). Brieﬂy, cDNAs were
subcloned into the “entry vector” pENTR–D-TOPO and recombined
into the “destination vector” pDEST8 according to the manufacturer's
recommendations. The sequence of pDEST8 clones was conﬁrmed by
the Keck DNA sequencing facility (New Haven, CT). pDEST8 clones
were transformed into DH10Bac cells (Invitrogen) which generated
recombinant bacmid that was isolated and puriﬁed from the
DH10Bac cells according to manufacturer's recommendations. The
presence of P2X cDNA in the bacmid was conﬁrmed by PCR. 1 μg of
the recombinant bacmid DNA was used to transfect Sf9 cells.
2.3. Culture, transfection, and harvesting of Sf9 cells
Serum-free medium (SFM) adapted Sf9 cells (Invitrogen) were
seeded at a density of 9×105 cells per well in a 6-well plate that con-
tained 2 ml of Sf-900 II SFM (Invitrogen). Cells were allowed to attach
for 1 hour at 27 °C, the medium was removed and cells were trans-
fected by drop-wise addition of transfection mixture (1 μg bacmid,
6 μl cellfectin, 1 ml Sf-900 II SFM). Cells were incubated with the
transfection mixture for 5 hours at 27 °C, after which time the trans-
fection mixture was aspirated and replaced with 2 ml of Sf-900 II
SFM. Transfected cells were incubated for 3 days at 27 °C and the
supernatant (presumed to contain a low-titer of baculovirus particles)
was harvested. 60 μl of the supernatantwas used to infect further insect
cells in a 6-well plate to produce 2 ml of high-titer viral stock. The viral
titer was determined to be 2×107 using the BacPAK baculovirus rapid
titer kit (Clontech, Mountain View, CA) and expression of P2X in these
cells was conﬁrmed by Western blotting using an anti-His antibody
(GE Healthcare, Waukesha, WI). This high-titer viral stock was used to
infect progressively larger volumes of Sf9 cells that were cultured in
suspension in ProCulture spinner ﬂasks (Corning Inc., Corning, NY),
which in turn generated progressively larger volumes of high-titer
viral stock. Finally, 1 L of Sf9 cells grown in suspension culture to a
density of 1×106 cells/ml in Sf-900 II SFM were infected with viral
particles at a multiplicity of infection of 0.5 (viral particles per cell).
After 3 days, we harvested cell pellets by centrifugation at 500g for
15 minutes. Cell pellets were stored at−80 °C.
2.4. Sf9 cell membrane preparation, detergent screening and PFO–PAGE
All steps were performed on ice and protease inhibitors were pre-
sent throughout. Sf9 cells from a 5-litre culture were resuspended in
50 ml phosphate-buffered saline (PBS) and disrupted by sonication
for 6×5 seconds at 40% amplitude, with 10 seconds rest between
pulses. Lysis was judged to be complete by light microscopy. Cell
lysates were centrifuged at 2000g for 2×5 minutes to pellet cell
2861M. Valente et al. / Biochimica et Biophysica Acta 1808 (2011) 2859–2866debris. Membranes were recovered from the supernatant by centrifu-
gation at 100,000g for 40 minutes, washed once with PBS pH 9.0 and
once with PBS containing 500 mM NaCl and resuspended in PBS.
Samples of insect cell membranes corresponding to cells from
approximately 10 ml total culture volume were solubilized in TBS
containing 1% (w/v) detergent (see Fig. 1 for detergents used) for
1 hour on ice, and centrifuged at 100,000g for 1 hour to pellet non-
solubilized material. Equal volumes of supernatant (containing
solubilized membrane protein) were mixed 1:1 with perﬂuoro-
octanoic acid (PFO)–PAGE loading buffer (ﬁnal concentration of 4%
(w/v) PFO) [17], separated on 6% (w/v) gels and subjected toWestern
blotting.
2.5. Pull-down assays with ATP-coupled sepharose beads
100 μg samples of protein solubilized in PBS containing 1% (w/v)
n-dodecyl-β-D-maltoside (DDM) were incubated with 20 μl of either
γ-amino-hexyl ATP-, 8-amino-hexyl ATP- or N6-(4-amino)-hexyl
ATP-sepharose beads (Jena Bioscience) for 1 hour at room tempera-
ture. Samples were centrifuged at 5000g for 1 minute to pellet
beads, and the supernatant was removed (Flow fraction). Beads
were washed with 3×0.5 ml of PBS containing 0.1% DDM, and protein
was eluted by incubation with 100 μl 10 mM ATP (in PBS containing
0.1% DDM) for 5 minutes. The elution fraction was removed, and
100 μl SDS–PAGE sample buffer was added to the beads, which
were boiled for 5 minutes at 100 °C to elute bound protein still
bound to the beads. 10 μl samples of each fraction were separated
by SDS–PAGE and subjected to Western blotting.
2.6. Protein puriﬁcation
DDM-solubilized Sf9 cell membranes from a 5-litre culture were
mixed 1:1 with wash buffer (Tris-buffered saline (20 mM Tris–HClA
B
Fig. 1. Detergent screening of hP2X4 and DdP2XA. Western blots (anti-His tag) of 10 μg
membrane protein samples of hP2X4 (A) or DdP2XA (B) solubilized in a 1% (w/v)
solution of each detergent indicated and separated using PFO–PAGE. Total, membrane
suspension; SDS, sodium dodecyl sulfate; DDM, n-dodecyl-β-D-maltoside; β-OG,
n-octyl-β-D-glucoside; TX-100, Triton-X-100; FC-12, n-dodecylphosphocholine;
C12E8, octaethylene glycol monododecyl ether; LDAO, n-dodecyl-N,N-dimethylamine-
N-oxide. Bands corresponding tomonomers (1), dimers (2) and trimers (3) are indicated.
Markers in kDa. *, partial degradation of DdP2XA.pH 7.9, 150 mM NaCl) containing 25 mM imidazole and 0.05%
DDM) and 500 μl Ni-sepharose beads (GE healthcare) and incubated
overnight at 4 °C to bind DdP2XA-(His)6 protein. The mixture was
poured into an empty PD-10 column (with bottom frit; GE health-
care) and the ﬂow-through fraction was allowed to pass through. A
second frit was added above the beads to prevent drying. Beads
were washed with 20 ml wash buffer and DdP2XA was eluted in a
step-wise fashion using 2×0.5 ml aliquots of wash buffer containing
100, 200, 300, 400 and 500 mM imidazole. Samples were separated
by SDS–PAGE and gels were stained with InstantBlue (Expedeon) to
detect protein. To selectively purify DdP2XA trimers, elutions con-
taining DdP2XA were pooled and concentrated to a volume of 1 ml
in 100-kDa cut-off Vivaspin-6 centrifugal concentrators (Generon).
The pooled part-puriﬁed DdP2XA was then mixed 1:1 with PFO–
PAGE sample buffer and applied to an 8% (w/v) polyacrylamide tube
gel in a cooled Bio-Rad 491 prep-cell in a cold room (4 °C). The gel
was run at 12 W constant power, and 1 ml elutions were collected
at a ﬂow rate of 0.1 ml/minute once the dye front reached the bottom
of the gel. Thirty fractions in total were collected; thesewere pooled into
6×5 ml fractions and concentrated to approximately 1 ml in 100-kDa
cut-off Vivaspin-6 centrifugal concentrators. Samples of each fraction
were subjected to PFO–PAGE and gels were stained with InstantBlue
to determine the location of DdP2XA trimers within the fractions.
2.7. Transmission electron microscopy and single particle analysis
Protein samples (50 μg/ml in Tris-buffered saline containing 0.05%
DDM) were adsorbed on to glow-discharged carbon-coated copper
grids and negatively stained with 2% (w/v) uranyl acetate. Transmis-
sion electron microscopy images were recorded at a specimen level
increment of 3.30 Å/pixel using a Jeol JEM-1200 electron microscope
operating at 100 kV, equipped with a 2 k Gatan Orius camera, at the
University of Manchester. EMAN software [18] was used to manually
select, ﬁlter, and process 5021 particles in 64×64 pixel boxes. The
ﬁnal model was generated from a total of 32 iterations of reﬁnement
(the ﬁnal 8 iterationswith un-ﬁltered particles) and Fourier shell corre-
lation (FSC) analysis of structures generated from even-and odd-
numbered particles using the command “eotest” indicated a resolution
of ~21 Å. Structures were displayed at volume shells corresponding to
at least 3 S.D. values above the mean density using UCSF Chimera [19].
2.8. Homology modeling
Sequences of 51 full-length P2X receptors were aligned using
ClustalW (EBI) to obtain an optimal alignment within the boundaries
of the zfP2X4.1 sequence contained within the crystal structure. Pair-
wise alignments of zfP2X4.1 and either hP2X4 or DdP2XA were pre-
pared from the full alignment for use in the program Modeller [20]. In
addition, a manual pairwise alignment of zfP2X4.1 and DdP2XA was
prepared where DdP2XA lacks the majority of the cysteine-rich head
domain (Supp. Fig. S1; based on an alignment published by Surprenant
and North [3]). A trimer structure of zfP2X4.1, prepared from PDB code
3H9V, was used as the template, and 5models were prepared using the
standard script (model-default.py). Eachmodelwas assessed for quality
usingMolProbity [21] and the best model was subjected to energymin-
imization in UCSF Chimera [19]. This step further improved the quality
of the models (as measured by MolProbity).
3. Results
3.1. Expression and trimer formation of hP2X4 and DdP2XA
To measure the degree of trimer formation after solubilization in
detergent, aliquots of resuspended membranes corresponding to
10 ml original culture (0.2% total volume) were used in detergent
screening experiments (Fig. 1). Samples were subjected to PFO–
AB
C
Fig. 2. Binding of hP2X4 and DdP2XA to ATP-coupled sepharose beads. A: Chemical
structure of ATP showing coupling to sepharose beads at the γ-, 6-amino- or 8-
positions. B, C: Western blots (anti-His tag) of equal volumes of DDM-solubilized
membrane protein samples of hP2X4 (B) or DdP2XA (C) before and after incubation
with sepharose beads (control), γ-ATP coupled beads (γ), 6-amino-ATP coupled
beads (6) or 8-ATP coupled beads (8). Flow, unbound protein; Elution, protein released
by incubation with 10 mM ATP; Bound, protein remaining on the beads after elution.
Markers in kDa.
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is a much milder detergent than SDS; it coats proteins with negative
charge but does not denature them. It has been used previously to
analyze the oligomeric state of a number of different membrane pro-
teins [17], as well as hP2X4 and DdP2XA expressed in human cells
[5,13]. Both untreated (total) and SDS-solubilized membranes (SDS)
were included as controls. Monomeric hP2X4 displayed a molecular
mass of approximately 55 kDa on PFO–PAGE gels (Fig. 1A); bands of
110 kDa (corresponding to dimer) were most prominent in samples
treated with no detergent (Total), DDM, Triton X-100 (TX-100) and
n-dodecylphosphocholine (FC-12). Bands of 165 kDa (trimers) were
very faint in TX-100 and virtually absent in all other samples, including
untreated membranes, leading to the conclusion that hP2X4 expressed
in insect cells does not form stable trimers. No dimer or trimer forma-
tion was observed in SDS. Monomeric DdP2XA also displayed a mass
of approximately 55 kDa on PFO–PAGE gels (Fig. 1B; SDS-treated
lane). In addition, a band at 35 kDa was also observed in some samples
(Fig. 1B; *); this probably represents a degradation product of the full-
length receptor. The untreated membrane fraction was a smear of
several bands and was difﬁcult to interpret, but in the detergent-
treated samples, bands corresponding to dimers and trimers were
observed (Fig. 1B). The trimer bands were the major species in
n-octyl-β-D-glucoside (β-OG), octaethylene glycol monododecyl ether
(C12E8) and DDM, leading to the conclusion that DdP2XA formed stable
trimers in a variety of detergents. A small proportion of trimer forma-
tion was observed in SDS, which may indicate the inherent stability of
the receptor, or a proportion of misfolded protein which is aggregating.
However, nohighermolecularmass species than trimerswere observed
in SDS, which would argue against non-speciﬁc protein aggregation.
3.2. Expressed protein binds to ATP-coupled sepharose beads
Our initial intention was to trial a number of different ATP-coupled
resins for use as a second afﬁnity-puriﬁcation step. To this end, we incu-
bated DDM-solubilized membranes with sepharose beads coupled to
ATP at the γ- 6-amino or 8-position in batch phase (Fig. 2), and eluted
protein with 10 mM ATP. Blank sepharose beads were used as a nega-
tive control, and samples of beads were boiled in SDS–PAGE sample
buffer to check for bound protein. Both hP2X4 (Fig. 2B) and DdP2XA
(Fig. 2C) bound to beads coupled at the γ- and 6-amino positions, and
a proportion of protein could be eluted with 10 mM ATP. However, a
signiﬁcant amount of P2X receptor did not bind (Flow), and also, a
signiﬁcant amount of the receptor that did bind could not be eluted
from the beads with 10 mM ATP (Bound). Neither receptor bound to
control beads, nor beads coupled at the 8-position, indicating that the
binding was speciﬁc, and implying that the extracellular domains of
the receptors retain their ATP-binding capability when solubilized in
DDM. It is possible that, when scaled up to a column format, problems
with low binding and elution may be resolved, and ATP-coupled
sepharose beads may represent a useful afﬁnity puriﬁcation procedure
for P2X receptors, but we decided to proceed with other methods to
purify DdP2XA trimers.
3.3. Expression and puriﬁcation of DdP2XA
Membranes from a 5-litre culture of Sf9 cells expressing DdP2XA
were solubilized in DDM and ﬁrst-stage puriﬁcation was carried out
in batch phase using nickel-sepharose beads to bind the His-tag
(Fig. 3A). Partially pure DdP2XA was eluted with increasing concen-
trations of imidazole; the majority of DdP2XA (major band at
45 kDa on SDS–PAGE; indicated with an arrow) eluted from 300 to
500 mM imidazole. Strong contaminating bands were observed at
100 and 200 kDa; these eluted from 100 to 400 mM imidazole. Pre-
parative PFO–PAGEwas then used to purify DdP2XA trimers to homo-
geneity, using a scaled-up version of the method employed
previously to purify hP2X4 from human cells [13]. Samples wereseparated on an internally cooled tube gel in a Bio-Rad 491 prep-
cell. At the bottom of the gel, protein is prevented from diffusing
into the running buffer by a chamber bounded by dialysis membrane,
and cooled elution buffer ﬂows through this chamber to a fraction
collector. Groups of fractions were pooled, concentrated and separat-
ed by PFO–PAGE to check the location of the trimer fraction (Fig. 3B).
Fraction 1 contained monomeric DdP2XA and other impurities, frac-
tion 2 contained a mixture of dimer and trimer, fraction 3 contained
pure trimers, and fractions 4–6 contained high molecular mass impu-
rities. The total yield of pure trimeric DdP2XA was estimated to be
approximately 1 mg per 5-litre culture by comparison to known
quantities of bovine serum albumin on Coomassie-stained gels.
3.4. TEM, single particle analysis and 3D structure of DdP2XA
Puriﬁed DdP2XA trimers were diluted to a concentration of
50 μg/ml and adsorbed on to carbon-coated copper grids for trans-
mission electron microscopy (TEM). A sample TEM image ﬁeld con-
taining single particles is shown in Fig. 4A. Particles were highly
homogeneous and monodisperse, and a total of 5021 particles were
selected in 64×64 pixel boxes (3.30 Å/pixel) for 3D reconstruction.
AB
Fig. 3. Puriﬁcation of DdP2XA by afﬁnity chromatography and preparative PFO–PAGE.
A: Coomassie-stained gel of the ﬁrst-stage nickel-sepharose puriﬁcation of DdP2XA
from a 5-litre culture of Sf9 cells. The band corresponding to monomeric DdP2XA,
which elutes in the 300–500 mM imidazole fractions, is indicated with an arrow. B:
Coomassie-stained PFO–PAGE gel representing pooled fractions (numbers 1–6) from
preparative PFO–PAGE. Bands corresponding to monomer (1), dimer (2) and trimer
(3) are indicated. Fraction 3 contained pure DdP2XA trimers. Markers in kDa.
A B
C
Fig. 4. Electron microscopy and single particle analysis of DdP2XA. A: Sample TEM
image ﬁeld (3.30 Å/pixel) of DdP2XA single particles negatively stained with 2%
(w/v) uranyl acetate. Single particles are represented in 64×64 pixel boxes. B: Selected
symmetrized reprojections (left) compared with 2D class averages (right) from the
ﬁnal 3D structure. A good correlation is observed, indicating that the ﬁnal structure is
a fair reﬂection of the input particles. C: Fourier shell correlation (FSC) analysis of
structures of wild-type DdP2XA generated from even- and odd-numbered particles
obtained using the command “eotest.” The resolution of the structure given by the
FSC value of 0.5 is indicated and corresponds to ~21 Å.
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trized reprojections from the ﬁnal 3D structure (Fig. 4B) was excellent.
Fourier shell correlation (FSC) analysis of structures generated from
even-and odd-numbered particles using the command “eotest” indicated
a resolution of ~21 Å (Fig. 4C). The low-resolution 3D structure of
DdP2XA displays a prominent extracellular domain propeller (Fig. 5A).
The overall dimensions of DdP2XA are similar to those of hP2X4
(Fig. 5B) and the zfP2X4.1 crystal structure (Fig. 5C); however, in
DdP2XA the propeller appears to be signiﬁcantly more pronounced than
in hP2X4 (Fig. 5B). When the structure of zfP2X4.1 is ﬁt within the
DdP2XA particle structure (Fig. 5C), there is a very good ﬁt with the
head domain of the extracellular domain, and a poor ﬁt with the trans-
membrane domains (expected due to the DDM micelle present in the
single particle structure).
3.5. N-glycosylation mutagenesis and homology modeling of hP2X4 and
DdP2XA
To probe the differences that we observed between the low-
resolution structures of hP2X4 and DdP2XA, we generated (i)
single-point mutants at each of the potential N-glycosylation consen-
sus sequences (Fig. 6A, B), and (ii) molecular models of each receptor
based upon the zfP2X4.1 crystal structure (Fig. 6C-E). DdP2XA lacks
many of the extracellular domain cysteine residues conserved in
mammalian P2X receptors, and it has recently been suggested that
the DdP2XA structure may lack the cysteine-rich head domain [3].
Because of this, we prepared two sequence alignments (Supp Fig. S1):
one based on a multiple sequence alignment (where the head domain
is present), and one based on a manual alignment (where the head
domain is absent [3]). From these alignments we constructed two
molecular models of DdP2XA: one containing the head domain
(Fig. 6D), and one model which lacks it (Fig. 6E). To provide an initialassessment of quality, the molecular models were manually ﬁtted
with the single particle structure of DdP2XA (Supp. Fig. S2), and it
was found that the model of DdP2XA containing the head domain
(Fig. 6D) gave the best ﬁt with the experimental data.
hP2X4 and DdP2XA contain 6 and 5 N-glycosylation consensus
sequences respectively (N-{P}-[ST]-{P}, where {P} represents any
amino acid except proline, and [ST] represents serine or threonine).
Point mutants for hP2X4 and DdP2XA were expressed in human
embryonic kidney (HEK) cells and separated by Western blotting. A
reduction in apparent molecular mass for a particular point mutant
was assumed to mean that this asparagine residue would normally
be N-glycosylated in HEK cells. All 6 mutants caused a reduction in
the molecular mass of hP2X4 (Fig. 6A), implying that each position
is N-glycosylated in HEK cells. This correlates well with the ﬁndings
of Qureshi et al., who observed six different N-glycosylation states
for rat P2X4 upon glycosidase treatment [22]. Additionally, all 6
sites were surface-exposed in the molecular model of hP2X4 based
upon the zfP2X4.1 crystal structure (Fig. 6C), suggesting that the
model is a good representation of the structure of hP2X4. For
DdP2XA, the results were more complex (Fig. 6B). First, due to the
relatively low expression of DdP2XA in HEK cells, more protein had
to be loaded, which increased the non-speciﬁc background (seen in
the non-transfected HEK lane). However, in all samples, 2 strong
bands were observed. Mutation of N-glycan sites at positions 75, 85,
195 and 230 caused a reduction in mass of both bands, whereas mu-
tation at position 130 caused no change, consistent with 4 of the 5
sites being N-glycosylated. In both molecular models of DdP2XA
based upon the zebraﬁsh P2X4.1 crystal structure (Fig. 6D, E), posi-
tions 75, 130 and 195 were predicted to be exposed, whereas posi-
tions 85 and 230 were predicted to be buried within the structure,
and thus not accessible for N-glycosylation. While positions 75 and
BC
Propeller
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A
Fig. 5. 3D structure of Dd2XA derived from single particle analysis. A: Top, side and bottom views of the DdP2XA single particle structure obtained from 5021 single protein par-
ticles. The pronounced extracellular domain propeller is indicated with an arrow. B: Top, side and bottom views of the ﬁt of DdP2XA within the previously determined structure of
hP2X4 (black mesh) [13], showing the similarity of the overall dimensions. C: Top, side and bottom views of the ﬁt between DdP2XA (black mesh) and the crystal structure of
zfP2X4.1 (PDB ID:3I5D; green ribbon). The extracellular domain ﬁt is good but the transmembrane domain ﬁt is poor due to the presence of the DDM micelle in the single particle
structure. The approximate position of the transmembrane domain is indicated with dashed lines. Scale bar=5 nm.
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not glycosylated but accessible, and positions 85 and 230 are glycosy-
lated but not accessible. These discrepancies strongly suggest that
neither molecular model of DdP2XA is a fair representation of its
native structure.4. Discussion
In the present study we have used Sf9 insect cell culture to express
full-length wild-type hP2X4 and DdP2XA, measuring trimer forma-
tion in detergent and binding to ATP-coupled sepharose beads. We
found that DdP2XA forms stable trimers in DDM, and puriﬁed
DdP2XA trimers to homogeneity using preparative PFO–PAGE,
obtaining a yield of approximately 1 mg pure trimers from a 5-litre
culture. Using TEM and single particle analysis, we were able to deter-
mine the 3D structure of DdP2XA at a resolution of 21 Å. In addition,
we have generated molecular models of hP2X4 and DdP2XA basedupon the zfP2X4.1 crystal structure, and probed their accuracy using
N-glycosylation mutagenesis.
Sf9 cells have been used previously to express several different
P2X receptor subtypes, including rat P2X2 [14,15,23,24], rat P2X3
[24] and zfP2X4.1 [6], and thus represent a proven expression system.
The apparent molecular mass of both hP2X4 and DdP2XA monomers
(55 kDa and 45–50 kDa respectively) was somewhat lower than that
obtained upon expression in human cells (60 kDa [13] and 45–55 kDa
[5] respectively). This reﬂected the differential glycosylation con-
ferred by the different expression systems, because treatment of
both human- and insect cell-derived hP2X4 with PNGaseF reduced
both bands to the same molecular mass (data not shown).
For hP2X4, the degree of trimer formation for protein produced in
Sf9 cells was virtually zero in any detergent tested, whichwasmarkedly
different to the ﬁgure of approximately 50% trimer for DDM-solubilized
hP2X4 derived from stably transfected human cells [13]. It is possible
that this was due to a high degree of over-expression in the insect cell
system leading to the accumulation of incorrectly processed hP2X4
A C
E
B
D
Fig. 6. N-glycosylation mutagenesis and molecular modeling of hP2X4 and DdP2XA.
Western blots (anti-His tag) of wild-type and potential N-glycosylation site mutants
for hP2X4 (A, 10 μg protein/lane) and DdP2XA (B, 50 μg protein/lane). Protein was de-
rived from expression in HEK-293 cells. A reduction in apparent molecular mass
indicates that the site is normally glycosylated in HEK cells. All 6 potential sites are
utilized in hP2X4, whereas 4 of the 5 sites (Asn75, Asn85, Asn195 and Asn230) appear
to be utilized in DdP2XA. Molecular models of hP2X4 (C) and DdP2XA both
containing (D) and lacking (E) the cysteine-rich head domain (from alignments in
Supp. Fig. 1) showing the positions of predicted accessible (red spheres) or inaccessible
(orange spheres) N-glycan acceptor sites on one subunit (gold). All 6 sites in the model
of hP2X4 are surface-accessible; however, only Asn75, Asn130 and Asn195 are surface-
accessible in either DdP2XA model. Although Asn85 and Asn230 appear to be
N-glycosylated in HEK cells, they are not accessible at the surface of the molecular
models.
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human cells, the lower over-expression level gives the protein more
time to beprocessed correctly. Alternatively, itmay be due to incompat-
ibility between the human protein sequence and the insect expression
system. It may be possible to use mutagenesis at the subunit interfaces
of hP2X4 to strengthen the trimerwithout compromising channel func-
tion; if not, then mammalian expression systems represent the best
route for production of hP2X4 for structural studies.
For DdP2XA, a large proportion of stable trimers were present in a
variety of detergents, and a similar degree of trimer formation has
been observed previously for DdP2XA expressed in human cells [5].
The fact that DdP2XA forms stable trimers in detergent makes it an
ideal candidate for structure determination. In this work we have
determined a low-resolution structure from single protein particles,
but efforts to prepare both 2D- and 3D crystals for higher-resolution
studies are ongoing.
One of the most interesting ﬁndings of this study is that both
DDM-solubilized hP2X4 and DdP2XA were capable of binding toATP-coupled sepharose beads. The ATP binding sites on P2X receptors
are located in the extracellular domain at the interface between sub-
units [6], so our data suggest that, at least, the extracellular domains
of the receptor are correctly folded. The binding properties of both
receptors were similar, suggesting that ATP occupies the binding
site in both receptors in a similar conformation. Both receptors
bound to beads coupled at the γ- and 6-amino-position, but not to
beads coupled at the 8-position. One way to interpret this result is
to suggest that both the γ-phosphate and the 6-amino group of the
adenine moiety must be at least partially exposed when ATP is
bound to the receptor, whereas the 8-carbon of the adenine moiety
is buried deep within the ATP binding site. Therefore an ATP analog
with a large substituent coupled at the 8-position would not be able
to bind to the receptor. This interpretation is supported by recent
data from Jiang et al., who demonstrated that the ATP analog NCS-
ATP (which contains a small, thiol-reactive NCS group, coupled at
the 8-position) was able to covalently label rat P2X2 cysteine mutants
at two positions (N140C and L186C) located deep within the putative
ATP binding site [25]. Our ﬁnding that hP2X4 (which formed a very
low proportion of oligomers in detergent) bound to ATP-coupled
beads implies that the presence of a partial binding site may be sufﬁ-
cient to permit ATP binding. These data could be extended in future
experiments by performing binding assays using ATP analogs con-
taining substituents in various positions around the molecule; a
cross-linking approach such as that employed by Roberts and Evans
on P2X1 [26] could also be used.
Using preparative PFO–PAGE, we were able to isolate homoge-
neous trimers for structural study. The signiﬁcant advantage of pre-
parative electrophoresis over gel ﬁltration chromatography is that it
is possible to purify several milligrams of protein in one step, without
having to use large columns. We are unable to state that PFO–PAGE
does not adversely affect P2X receptor structure, because we have
not yet been able to overcome the challenges associated with assay-
ing the ion channel function of puriﬁed receptors. However, it has
been shown that, after puriﬁcation in PFO, the cystic ﬁbrosis trans-
membrane conductance regulator (CFTR) retains its function, demon-
strating that PFO–PAGE does not severely affect the structure of this
particular membrane protein [27].
Puriﬁed DdP2XA trimers appeared homogeneous and monodis-
perse under TEM, and we were able to generate a 21 Å-resolution
3D structure, which possessed similar overall dimensions to the pre-
viously determined hP2X4 structure [13] (albeit with signiﬁcantly
pronounced extracellular domain propellers) and the zfP2X4.1 crystal
structure [6]. The lateral propellers that we observed in the DdP2XA
single particle structure ﬁt well with the cysteine-rich head domain
of zfP2X4.1. In addition, a molecular model of DdP2XA containing
the head domain was a better ﬁt to the single particle structure
than a model of DdP2XA which lacked the head domain. These data
imply that the structure of DdP2XA does contain head domains, even
though it lacks the majority of conserved cysteine residues within this
region, and has been suggested to lack this domain entirely [3].
To probe the structures further, we generated N-glycosylation
mutants and used them to validate molecular models of hP2X4 and
DdP2XA based on the zfP2X4.1 crystal structure. Our data showed
that each of the 6 predicted N-glycan sites on hP2X4 was utilized
and predicted to be surface-exposed in the molecular model, implying
that the structure of hP2X4 is very similar to that of zfP2X4.1. This is
to be expected given the high degree of sequence identity between
the two receptors (57%). However, for DdP2XA, only 4/5 of the
N-glycan sites were used, and only 3/5 were predicted to be accessible
in either molecular model. Asn130 was not glycosylated, but was pre-
dicted to be surface-exposed in the models. Both Asn85 and Asn230
were glycosylated, but were not predicted to be surface-exposed in
the models. These discrepancies strongly imply that the molecular
models of DdP2XA based on the zfP2X4.1 crystal structure are inaccu-
rate; this is not surprising given the low degree of amino-acid sequence
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of homology modeling is dependent on sequence identity. The discrep-
ancies in N-glycosylation and the predictions of the molecular model
strongly suggest that the structure of DdP2XA is signiﬁcantly different
to that of P2X receptors from higher eukaryotes. Higher-resolution
structural data will be required to conﬁrm whether or not this is the
case, but it is worth noting the potential errors that could be made by
over-interpretation of molecular models derived from sequence align-
ments which display poor homology.
In summary, we have exploited the Sf9 insect cell system to express
hP2X4, and express and purify DdP2XA for direct structural study. We
have developed a straightforward pull-down assay to test ATP binding
capability, and used N-glycosylation mutagenesis both to conﬁrm the
extent of N-linked glycosylation on hP2X4 and DdP2XA and validate
homology models of the two receptors. Our work contributes to the
understanding of the factors necessary for the successful expression
and puriﬁcation of P2X receptors, highlights the need for construct
modiﬁcation to stabilize trimers (in the case of hP2X4) and demon-
strates that DdP2XA is both an interesting and ideal candidate with
which to pursue higher-resolution structural studies.
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